Insiders · Profile

SHERWIN STEPHEN A

Director at NEUROCRINE BIOSCIENCES · Director at Biogen · Director at Verastem. Filing since 19 Dec 2011. CIK 0001079462

NBIX NEUROCRINE BIOSCIENCES INC Director · 7 trades BIIB Biogen Director · 9 trades VSTM Verastem, Inc. Director · 1 trade

Company

Date

Role

Action

Shares

Amount

Of holding

NBIX NEUROCRINE BIOSCIENCES INC

5 Jun 2026

Director

Sold on a plan

25,000

$4.13M

61.2%

7 Mar 2025

Director

Sold on a plan

8,760

$1.31M

43.6%

NBIX NEUROCRINE BIOSCIENCES INC

13 Feb 2025

Director

Sold on a plan

13,831

$1.61M

56.4%

NBIX NEUROCRINE BIOSCIENCES INC

29 May 2024

Director

Sold on a plan

40,000

$5.34M

60.1%

NBIX NEUROCRINE BIOSCIENCES INC

3 Jan 2023

Director

Sold, plan not stated

30,000

$3.57M

54.5%

NBIX NEUROCRINE BIOSCIENCES INC

24 Jan 2022

Director

Sold, plan not stated

15,000

$1.12M

37.4%

NBIX NEUROCRINE BIOSCIENCES INC

28 Apr 2020

Director

Sold, plan not stated

17,687

$1.76M

37.2%

11 Mar 2020

Director

Sold, plan not stated

2,434

$718.57K

14.5%

NBIX NEUROCRINE BIOSCIENCES INC

11 Jun 2018

Director

Sold, plan not stated

10,000

$984.42K

17.4%

10 Mar 2015

Director

Sold, plan not stated

6,000

$2.46M

59.1%

VSTM Verastem, Inc.

26 Dec 2014

Director

Bought

2,500

$21.40K

opened

2 Jan 2014

Director

Sold, plan not stated

5,500

$1.54M

58.1%

3 Jun 2013

Director

Sold, plan not stated

12,825

$2.99M

82.8%

22 Mar 2013

Director

Sold, plan not stated

1,500

$265.32K

36.1%

4 Sep 2012

Director

Sold, plan not stated

2,000

$291.80K

32.5%

4 Jun 2012

Director

Sold, plan not stated

2,500

$316.13K

37.7%

19 Dec 2011

Director

Sold, plan not stated

2,500

$277.20K

27.4%

17 decisions on file.